Advertisement

Corrigendum to ’Why PGT-A, most likely, improves IVF success’ Reproductive BioMedicine Online Volume 45, Issue 4, (2022) 633-637

Published:November 12, 2022DOI:https://doi.org/10.1016/j.rbmo.2022.11.004
      The author regrets that, on page 634, the outcome measure of the RCT by Yan et al. (2021) was given as cumulative pregnancy rate, rather than cumulative live birth rate.
      The author apologises for any inconvenience caused.

      Linked Article

      • Why PGT-A, most likely, improves IVF success
        Reproductive BioMedicine OnlineVol. 45Issue 4
        • Preview
          Preimplantation genetic testing for aneuploidies (PGT-A), with its vocal advocates and opponents, is at the epicentre of a perpetual, often heated, debate. The main issues include the following. First, how do we interpret the existing evidence-base? Around 100 retrospective and single-centre studies, two non-selection trials and at least two meta-analyses point to its efficacy in improving live birth rates, although randomized controlled trials are more mixed. Second, what should be done in relation to euploid/aneuploid mosaicism? Recent data suggest that low-level mosaic pregnancies can proceed uneventfully to term, so intelligent interpretation of the diagnostic data is appropriate.
        • Full-Text
        • PDF